United States · FDA National Drug Code directory
dapsone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 13668-605_2c733874-9036-42d0-8820-d5a4a35b5adc
- Product NDC
- 13668-605
- Form
- GEL
- Composition / generic term
- dapsone
- Labeler
- Torrent Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220210
- Source listing expiry
- 20261231
Source-listed ingredients
- DAPSONE — 75 mg/g
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, PUMP in 1 CARTON (13668-605-05) / 60 g in 1 BOTTLE, PUMP · 13668-605-05
- 1 BOTTLE, PUMP in 1 CARTON (13668-605-08) / 90 g in 1 BOTTLE, PUMP · 13668-605-08
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →